Blog Big Molecule Watch February 14, 2019

Mundipharma Launches Pegfilgrastim Biosimilar in Europe

On February 5, 2019, Mundipharma announced the European launch of Pelmeg® (pegfilgrastim), a biosimilar of Neulasta®.  As we have previously reported, Mundipharma acquired Pelmeg® from Cinfa Biotech and it was approved by the European Commission in November 2018.  According to the press release, Pelmeg® is now available in Germany, the Netherlands, and Ireland, and the fourth biosimilar medicine to be commercialized by Mundipharma.

The post Mundipharma Launches Pegfilgrastim Biosimilar in Europe appeared first on Big Molecule Watch.